BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4572726)

  • 21. Effects of energy metabolism on the release of bound proflavine from sensitive and resistant Escherichia coli.
    Mehta BM; Gravelle MJ; Kushner DJ
    Antimicrob Agents Chemother; 1973 Sep; 4(3):332-6. PubMed ID: 4586148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valine accumulation by alpha-aminobutyric acid-resistant mutants of Serratia marcescens.
    Kisumi M; Komatsubara S; Chibata I
    J Bacteriol; 1971 May; 106(2):493-9. PubMed ID: 4929861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SELECTIVE INHIBITION OF PROLINE-INDUCED PIGMENTATION IN WASHED CELLS OF SERRATIA MARCESCENS.
    BLIZZARD JL; PETERSON GE
    J Bacteriol; 1963 May; 85(5):1136-40. PubMed ID: 14044006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of temperature of incubation and type of growth medium on pigmentation in Serratia marcescens.
    Williams RP; Gott CL; Qadri SM; Scott RH
    J Bacteriol; 1971 May; 106(2):438-43. PubMed ID: 4929859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of lysine-sensitive aspartokinase in threonine production by S-2-aminoethyl cysteine-resistant mutants of Serratia marcescens.
    Komatsubara S; Kisumi M; Chibata I
    Appl Environ Microbiol; 1979 Nov; 38(5):777-82. PubMed ID: 232391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of streptomycin resistance, caffeine and acriflavine on ultraviolet light-induced reversion to tryptophan independence in strains of Escherichia coli B/r.
    Barfknecht TR; Shankel DM
    Mutat Res; 1975 Nov; 30(2):163-76. PubMed ID: 1107829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of a histidine-producing strain of Serratia marcescens.
    Sugiura M; Kisumi M
    Appl Environ Microbiol; 1984 Jul; 48(1):43-7. PubMed ID: 6383217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transductional analysis of the leu-thr region of chromosome of Serratia marcescens.
    Matsumoto H; Tazaki T; Hosogaya S
    J Bacteriol; 1974 Mar; 117(3):1365-7. PubMed ID: 4591957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The elusive permeability barriers and binding sites for proflavine in Escherichia coli.
    Gravelle MJ; Mehta BM; Kushner DJ
    Antimicrob Agents Chemother; 1972 Jun; 1(6):470-5. PubMed ID: 4618456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular nature of the drug-resistance factors of the Enterobacteriaceae.
    Rownd R; Nakaya R; Nakamura A
    J Mol Biol; 1966 Jun; 17(2):376-93. PubMed ID: 4164241
    [No Abstract]   [Full Text] [Related]  

  • 32. Cation transport in Serratia marcescens and Serratia marinorubra.
    Gale NL; Dittman JB; Goldner BH
    J Bacteriol; 1970 Nov; 104(2):650-7. PubMed ID: 4923067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimorphism, sensitivity to nystatin and acriflavin uptake in a strain of Candida albicans grown with glutamate as sole nitrogen and carbon source.
    Nishioka Y; Silva-Hutner M
    Sabouraudia; 1974 Nov; 12(3):295-301. PubMed ID: 4610821
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of temperature, pH and NaCl content on in vitro putrescine and cadaverine production through the growth of Serratia marcescens CCM 303.
    Bubelová Z; Buňka F; Taťáková M; Štajnochová K; Purevdorj K; Buňková L
    J Environ Sci Health B; 2015; 50(11):797-808. PubMed ID: 26357890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second acriflavine sensitivity mutation, acrB, in Escherichia coli K-12.
    Nakamura H; Hachiya N; Tojo T
    J Bacteriol; 1978 Jun; 134(3):1184-7. PubMed ID: 350842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of chloramphenicol production in strains of Streptomyces species 3022alpha treated with acriflavine and ethidium bromide.
    Michelson AM; Vining LC
    Can J Microbiol; 1978 Jun; 24(6):662-9. PubMed ID: 667733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACRIFLAVINE RESISTANCE: A BACTERIOPHAGE MUTATION AFFECTING THE UPTAKE OF DYE BY THE INFECTED BACTERIAL CELLS.
    SILVER S
    Proc Natl Acad Sci U S A; 1965 Jan; 53(1):24-30. PubMed ID: 14283203
    [No Abstract]   [Full Text] [Related]  

  • 38. Range of spontaneous back-mutation rates in nitrosoguanidine induced auxotrophs of Serratia marcescens.
    Kaplan RW; Peters HV
    Mol Gen Genet; 1974; 132(2):165-71. PubMed ID: 4607873
    [No Abstract]   [Full Text] [Related]  

  • 39. Threonine production by regulatory mutants of Serratia marcescens.
    Komatsubara S; Kisumi M; Murata K; Chibata I
    Appl Environ Microbiol; 1978 May; 35(5):834-40. PubMed ID: 350154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel acriflavin resistance genes, acrC and acrD, in Escherichia coli K-12.
    Nakamura H
    J Bacteriol; 1979 Jul; 139(1):8-12. PubMed ID: 378962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.